IL-6 activated the STAT3 pathway by binding to IL-6 receptors on the surface of neutrophils surrounding cancer cells, increasing the expression of PD-L1 on the surface of neutrophils, inhibiting T cell activity further, accelerating OC immune escape, and ultimately promoting cancer cell growth and metastasis (82). This evidence concerns the gene CD274 and cancer.